TKT Trademark

Trademark Overview


On Friday, July 30, 1999, a trademark application was filed for TKT with the United States Patent and Trademark Office. The USPTO has given the TKT trademark a serial number of 75764341. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Saturday, November 10, 2007. This trademark is owned by Transkaryotic Therapies, Inc.. The TKT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals and biologics for use in the treatment of genetic disorders, cancer, hematologic disorders, endocrine disorders including reproductive dysfunction and metabolic disorders, disorders of the central nervous system, gastrointestinal disorders, cardiovascular disorders, autoimmune disorders and other disorders of the immune system, infectious disease and enzyme deficiency diseases; genetically altered cells and cell lines for use in production of human therapeutic proteins, for medical diagnostic use, for use in the treatment of a variety of diseases and disorders and for implantation into human patients
tkt

General Information


Serial Number75764341
Word MarkTKT
Filing DateFriday, July 30, 1999
Status710 - CANCELLED - SECTION 8
Status DateSaturday, November 10, 2007
Registration Number2427596
Registration DateTuesday, February 6, 2001
Mark Drawing5S09 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, February 22, 2000

Trademark Statements


Goods and ServicesPharmaceuticals and biologics for use in the treatment of genetic disorders, cancer, hematologic disorders, endocrine disorders including reproductive dysfunction and metabolic disorders, disorders of the central nervous system, gastrointestinal disorders, cardiovascular disorders, autoimmune disorders and other disorders of the immune system, infectious disease and enzyme deficiency diseases; genetically altered cells and cell lines for use in production of human therapeutic proteins, for medical diagnostic use, for use in the treatment of a variety of diseases and disorders and for implantation into human patients
Lining/Stippling StatementThe drawing is lined for the color blue, and blue is a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateSaturday, November 10, 2007
Primary Code005
First Use Anywhere DateMonday, April 10, 2000
First Use In Commerce DateMonday, April 10, 2000

Trademark Owner History


Party NameSHIRE HUMAN GENETIC THERAPIES, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02139

Party NameTranskaryotic Therapies, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameTranskaryotic Therapies, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameTranskaryotic Therapies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Saturday, November 10, 2007CANCELLED SEC. 8 (6-YR)
Friday, December 1, 2006CASE FILE IN TICRS
Tuesday, February 6, 2001REGISTERED-PRINCIPAL REGISTER
Tuesday, September 19, 2000ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, September 15, 2000ASSIGNED TO EXAMINER
Tuesday, September 12, 2000STATEMENT OF USE PROCESSING COMPLETE
Monday, July 17, 2000USE AMENDMENT FILED
Tuesday, May 16, 2000NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 22, 2000PUBLISHED FOR OPPOSITION
Friday, January 21, 2000NOTICE OF PUBLICATION
Tuesday, November 30, 1999APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 12, 1999ASSIGNED TO EXAMINER